In a row for medical cannabis patients: Minister of Health July Edelstein And his deputy Yoav Kish Announced today (Sunday) a special pilot, which will last until the end of the current year, and is expected to provide medical cannabis patients with an immediate solution regarding the price, until the completion of all the steps announced by the Labor, Welfare and Health Committee, about two months ago.
As part of the pilot, a large number of companies in the Israeli market will offer their products at discounted prices of NIS 140 per ten grams for adults, and NIS 100 per ten grams for young patients (up to the age of 21). In addition, the participating companies will be able to export their products worldwide The model
“Previous poor of your city” – ensuring supply to the local market and discounted prices.
The companies participating in the pilot are: Kandok, Panaxia, Better / The Agricultural Company, Unibo, BOL, Togder Pharma, Tikun Olam, Sheikh and Medican.
The Minister of Health explained that “after the medical cannabis consumers had to pay huge sums for the drug, I am glad that we started the process of discounting the product. Much more work is needed to make the price accessible and even after the pilot period and we will do so.”
The Deputy Minister of Health added: “I am pleased to announce a significant step that will make it easier for the patient public immediately on the issue of the most urgent price.
“This is a three-month trial that will provide an immediate price reduction, with a continuous supply of inventory, while opening up the export market to cannabis companies in the State of Israel.” More.
*The article has been translated based on the content of Source link by https://www.maariv.co.il/news/health/Article-793676
. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!